Published in Neurology on May 11, 2004
The incidence of herpes zoster in a United States administrative database. J Gen Intern Med (2005) 3.31
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
Herpes zoster. BMJ (2007) 1.91
Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open (2014) 1.81
Natural history of pain following herpes zoster. Pain (2006) 1.66
Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc (2011) 1.62
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax. Clin Vaccine Immunol (2007) 1.25
Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain (2006) 1.21
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med (2010) 1.15
Herpes zoster and postherpetic neuralgia: past, present and future. Pain Res Manag (2009) 1.10
Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother (2012) 1.05
A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain (2016) 1.04
Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study. Health Qual Life Outcomes (2014) 1.04
Brain dynamics for perception of tactile allodynia (touch-induced pain) in postherpetic neuralgia. Pain (2008) 1.01
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment. Korean J Pain (2015) 0.96
Managing ophthalmic herpes zoster in primary care. BMJ (2005) 0.92
Management and prevention of herpes zoster: A Canadian perspective. Can J Infect Dis Med Microbiol (2010) 0.92
Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses. Antimicrob Agents Chemother (2005) 0.92
Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms. Int J Environ Res Public Health (2009) 0.91
Preventing Chronic Pain following Acute Pain: Risk Factors, Preventive Strategies, and their Efficacy. Eur J Pain Suppl (2011) 0.90
Postherpetic neuralgia in the elderly. Int J Clin Pract (2009) 0.90
Pain and interference of pain with function and mood in elderly adults involved in a motor vehicle collision: a pilot study. Exp Aging Res (2012) 0.90
Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report. J Headache Pain (2012) 0.90
Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med (2007) 0.87
Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother (2013) 0.87
Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster. Ther Clin Risk Manag (2014) 0.86
Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics (2009) 0.86
Antibody to varicella-zoster virus immediate-early protein 62 augments allodynia in zoster via brain-derived neurotrophic factor. J Virol (2009) 0.82
Post-herpetic neuralgia. Int J Gen Med (2012) 0.82
The burden of disease of Herpes Zoster in Tuscany. Hum Vaccin Immunother (2014) 0.80
One-year follow-up of patients with long-lasting post-herpetic neuralgia. BMC Infect Dis (2014) 0.79
[Postherpetic neuralgia]. Schmerz (2014) 0.79
Herpes Zoster: the rationale for the introduction of vaccination in Italy. J Prev Med Hyg (2015) 0.78
Risk of Herpes Zoster and Family History: A Meta-analysis of Case-control Studies. Indian J Dermatol (2016) 0.78
Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study. BMC Complement Altern Med (2011) 0.77
Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin. Clin J Pain (2015) 0.75
Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study. BMJ Open (2016) 0.75
Prevalence and trends of pain associated with chronic diseases and personal out-of-pocket medical expenditures in Korea. Korean J Pain (2017) 0.75
Risk Factor and Prevention of Postherpetic Neuralgia. Korean J Pain (2015) 0.75
Efficacy of continuous epidural block in acute herpes zoster: Incidence and predictive factors of postherpetic neuralgia, a retrospective single-center study. Medicine (Baltimore) (2016) 0.75
Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study. PLoS One (2016) 0.75
Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey. PLoS One (2016) 0.75
Presentation and management of herpes zoster (shingles) in the geriatric population. P T (2013) 0.75
Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. Trials (2017) 0.75
Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a three-years population-based study. Hum Vaccin Immunother (2016) 0.75
Postherpetic neuralgia #272. J Palliat Med (2013) 0.75
Can pontine trigeminal T2-hyperintensity suggest herpetic etiology of trigeminal neuralgia? Quant Imaging Med Surg (2016) 0.75
A questionnaire study investigating the prevalence of chronic postoperative pain. Korean J Anesthesiol (2012) 0.75
Effects of pregabalin on acute herpetic pain and postherpetic neuralgia incidence. Wien Klin Wochenschr (2010) 0.75
Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain (2008) 4.59
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain (2003) 4.24
The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain (2010) 3.51
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.71
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Treatment of neuropathic pain: an overview of recent guidelines. Am J Med (2009) 2.43
An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain (2007) 2.37
The impact of neuropathic pain on health-related quality of life: review and implications. Neurology (2007) 2.36
Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry (2009) 2.31
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis (2004) 2.14
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage (2006) 1.99
Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med (2005) 1.96
Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain (2006) 1.89
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89
Clinical trial outcome in neuropathic pain: relationship to study characteristics. Neurology (2008) 1.82
Congenital insensitivity to pain: an update. Pain (2003) 1.82
Pain associated with multiple sclerosis: systematic review and proposed classification. Pain (2007) 1.65
The burden of Herpes Zoster: a prospective population based study. Vaccine (2005) 1.61
Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain (2003) 1.57
Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis (2013) 1.54
Acute and chronic pain associated with leprosy. Pain (2015) 1.51
ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc (2005) 1.48
Tolerability of treatments for postherpetic neuralgia. Drug Saf (2004) 1.45
Risk factors for acute pain and its persistence following breast cancer surgery. Pain (2005) 1.44
Pain following herpes zoster: the influence of changing population characteristics and medical developments. Pain (2006) 1.43
Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med (2007) 1.41
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system. Pain (2016) 1.39
XPS and AFM analysis of antifouling PEG interfaces for microfabricated silicon biosensors. Biosens Bioelectron (2004) 1.30
What should be the core outcomes in chronic pain clinical trials? Arthritis Res Ther (2004) 1.26
A prospective study of the herpes zoster severity of illness. Clin J Pain (2010) 1.22
Evaluation of the stability of nonfouling ultrathin poly(ethylene glycol) films for silicon-based microdevices. Langmuir (2004) 1.17
Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk. Pain (2004) 1.16
Treatment of herpes zoster and postherpetic neuralgia. BMJ (2003) 1.13
Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol (2002) 1.12
Giant splenic artery aneurysm associated with arteriovenous malformation. J Vasc Surg (2006) 1.10
Clinical practice. Postherpetic neuralgia. N Engl J Med (2014) 1.08
Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. Pain (2005) 1.08
The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness. Obstet Gynecol (2009) 1.06
Current management of herpes zoster: the European view. Am J Clin Dermatol (2005) 1.06
Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol (2004) 1.05
Geographic and racial aspects of herpes zoster. J Med Virol (2003) 1.04
Natural history and treatment of herpes zoster. J Pain (2008) 1.02
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain (2012) 0.99
Use of the Rydel-Seiffer graduated tuning fork in the assessment of vibration threshold in postherpetic neuralgia patients and healthy controls. Eur J Pain (2005) 0.99
Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain (2011) 0.98
Pregabalin. Nat Rev Drug Discov (2005) 0.98
A quantitation method for mass spectrometry imaging. Rapid Commun Mass Spectrom (2011) 0.97
Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster. J Pain (2005) 0.97
Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice? Eur J Pain (2006) 0.96
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations. Pain (2012) 0.95
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis. Nat Clin Pract Neurol (2009) 0.94
Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol (2010) 0.93
Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med (2013) 0.93
Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use? Pain (2009) 0.92
Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial. Pain Med (2008) 0.92
Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol (2010) 0.91
Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med (2002) 0.91
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning? J Pain (2006) 0.90
Neuropathic pain associated with non-surgical treatment of breast cancer. Pain (2005) 0.90
What is localized neuropathic pain? A first proposal to characterize and define a widely used term. Pain Manag (2012) 0.89
Calystegines as chemotaxonomic markers in the Convolvulaceae. Phytochemistry (2005) 0.89
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics (2012) 0.89
Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry. J Mass Spectrom (2012) 0.88
Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother (2013) 0.87
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain (2005) 0.87
Coalition of advocates to vaccinate of Western European citizens aged 60 years and older. Aging Clin Exp Res (2009) 0.87
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations. Pain (2013) 0.87
Neuropathic pain in children: Special considerations. Mayo Clin Proc (2010) 0.86
An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med (2005) 0.84
A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain (2005) 0.83
Ion channel targets and treatment efficacy in neuropathic pain. J Pain (2006) 0.83
The impact of varicella zoster virus: chronic pain. J Clin Virol (2010) 0.83
Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region. Rejuvenation Res (2009) 0.83
Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies. Muscle Nerve (2006) 0.82
Contributions of physical and sexual abuse to women's experiences with chronic pelvic pain. J Reprod Med (2005) 0.82
Immobilization of RGD to < 1 1 1 > silicon surfaces for enhanced cell adhesion and proliferation. Biomaterials (2002) 0.82
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain (2016) 0.82
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain (2016) 0.81
Characterization of protein kinase A phosphorylation: multi-technique approach to phosphate mapping. Anal Biochem (2004) 0.81
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models. J Pharmacol Exp Ther (2007) 0.81
Oral ketamine for children with chronic pain: a pilot phase 1 study. J Pediatr (2013) 0.81
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol (2014) 0.81
Antifreeze proteins modify the freezing process in planta. Plant Physiol (2005) 0.81
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review. Pain (2012) 0.81
A snapshot and scorecard for analgesic clinical trials for chronic pain: the RReACT database. Pain (2012) 0.80
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations. Pain (2016) 0.80
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain (2015) 0.79
Broadening the spectrum of controls for skin biopsy in painful neuropathies. Muscle Nerve (2010) 0.79
Preventing chronic postsurgical pain: how much of a difference makes a difference? Anesthesiology (2010) 0.79
Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations. Pain (2013) 0.79